FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034333033> ?p ?o ?g. }

• W2034333033 endingPage "156" @default.
• W2034333033 startingPage "147" @default.
• W2034333033 abstract "Prostate cancer is the most common malignancy in Western countries. Chemokine C-X-C motif receptor 1 (CXCR1) and CXCR2 play a key role in generation and regulation of CXC chemokine signaling. CXCR1 is a receptor for interleukin 8 (IL8), a pro-inflammatory chemokine, and CXCR1/2 are crucially involved in the prostate cancer development and progression. Thus, we generated a high-affinity human CXCR1/CXCR2 inhibitor, CXCL8 (3-72) K11R/G31P, named G31P, which is a synthetic derivative of the human cytokine, IL-8. In this study, we investigated the effects of G31P on regulation of prostate cancer cell growth in vitro and in nude mouse xenografts. Cell viability, adhesion, and wound healing assays were used to assess the effects of G31P on growth, adhesion, and migration of PC-3 human prostate cancer cells in vitro, respectively. Nude mouse xenografts and xenograft implantation assays were performed to determine the effect of G31P on PC-3 cells in vivo. Immunohistochemistry was used to detect gene expression, and fluorescence imaging was used to detect tumor volume and microvessel density in tumor xenografts. The data showed that G31P treatment significantly reduced PC-3 cell viability, adhesion and migration capacity in a dose-dependent manner (up to 100 ng/ml). Additionally, G31P treatment of nude mice suppressed the growth of orthotopically transplanted tumor xenografts. G31P also inhibited tumor tissue vascularization, which was associated with the decreased expression of vascular endothelial growth factor and nuclear transcription factor (NF)-κB in orthotopic xenograft tissues. This study provides evidence that G31P, a CXCR1/2 inhibitor, may effectively control prostate cancer." @default.
• W2034333033 created "2016-06-24" @default.
• W2034333033 creator A5000784710 @default.
• W2034333033 creator A5021687717 @default.
• W2034333033 creator A5026567678 @default.
• W2034333033 creator A5026627455 @default.
• W2034333033 creator A5032104176 @default.
• W2034333033 creator A5038551826 @default.
• W2034333033 creator A5054308759 @default.
• W2034333033 creator A5079727555 @default.
• W2034333033 date "2012-01-01" @default.
• W2034333033 modified "2023-10-06" @default.
• W2034333033 title "G31P, an Antagonist against CXC Chemokine Receptors 1 and 2, Inhibits Growth of Human Prostate Cancer Cells in Nude Mice" @default.
• W2034333033 cites W1597147514 @default.
• W2034333033 cites W1636449792 @default.
• W2034333033 cites W1902473583 @default.
• W2034333033 cites W1912343035 @default.
• W2034333033 cites W1965734230 @default.
• W2034333033 cites W1975120553 @default.
• W2034333033 cites W1980350123 @default.
• W2034333033 cites W1981731027 @default.
• W2034333033 cites W1994803737 @default.
• W2034333033 cites W1996839696 @default.
• W2034333033 cites W2000542929 @default.
• W2034333033 cites W2010397777 @default.
• W2034333033 cites W2012315119 @default.
• W2034333033 cites W2014098577 @default.
• W2034333033 cites W2017285418 @default.
• W2034333033 cites W2022021401 @default.
• W2034333033 cites W2028628158 @default.
• W2034333033 cites W2029599962 @default.
• W2034333033 cites W2039137468 @default.
• W2034333033 cites W2044410366 @default.
• W2034333033 cites W2044904123 @default.
• W2034333033 cites W2058902088 @default.
• W2034333033 cites W2073717776 @default.
• W2034333033 cites W2087233597 @default.
• W2034333033 cites W2093312816 @default.
• W2034333033 cites W2110567472 @default.
• W2034333033 cites W2115620743 @default.
• W2034333033 cites W2125495763 @default.
• W2034333033 cites W2152105216 @default.
• W2034333033 cites W2157165833 @default.
• W2034333033 cites W2166559015 @default.
• W2034333033 cites W2167347313 @default.
• W2034333033 cites W2170037266 @default.
• W2034333033 cites W2171182747 @default.
• W2034333033 doi "https://doi.org/10.1620/tjem.228.147" @default.
• W2034333033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23019013" @default.
• W2034333033 hasPublicationYear "2012" @default.
• W2034333033 type Work @default.
• W2034333033 sameAs 2034333033 @default.
• W2034333033 citedByCount "22" @default.
• W2034333033 countsByYear W20343330332013 @default.
• W2034333033 countsByYear W20343330332014 @default.
• W2034333033 countsByYear W20343330332015 @default.
• W2034333033 countsByYear W20343330332016 @default.
• W2034333033 countsByYear W20343330332017 @default.
• W2034333033 countsByYear W20343330332019 @default.
• W2034333033 countsByYear W20343330332021 @default.
• W2034333033 countsByYear W20343330332022 @default.
• W2034333033 countsByYear W20343330332023 @default.
• W2034333033 crossrefType "journal-article" @default.
• W2034333033 hasAuthorship W2034333033A5000784710 @default.
• W2034333033 hasAuthorship W2034333033A5021687717 @default.
• W2034333033 hasAuthorship W2034333033A5026567678 @default.
• W2034333033 hasAuthorship W2034333033A5026627455 @default.
• W2034333033 hasAuthorship W2034333033A5032104176 @default.
• W2034333033 hasAuthorship W2034333033A5038551826 @default.
• W2034333033 hasAuthorship W2034333033A5054308759 @default.
• W2034333033 hasAuthorship W2034333033A5079727555 @default.
• W2034333033 hasBestOaLocation W20343330331 @default.
• W2034333033 hasConcept C121608353 @default.
• W2034333033 hasConcept C126322002 @default.
• W2034333033 hasConcept C12823836 @default.
• W2034333033 hasConcept C13373296 @default.
• W2034333033 hasConcept C170493617 @default.
• W2034333033 hasConcept C203014093 @default.
• W2034333033 hasConcept C2778690821 @default.
• W2034333033 hasConcept C2780192828 @default.
• W2034333033 hasConcept C2780278673 @default.
• W2034333033 hasConcept C2780394083 @default.
• W2034333033 hasConcept C502942594 @default.
• W2034333033 hasConcept C68324877 @default.
• W2034333033 hasConcept C71924100 @default.
• W2034333033 hasConcept C84913492 @default.
• W2034333033 hasConceptScore W2034333033C121608353 @default.
• W2034333033 hasConceptScore W2034333033C126322002 @default.
• W2034333033 hasConceptScore W2034333033C12823836 @default.
• W2034333033 hasConceptScore W2034333033C13373296 @default.
• W2034333033 hasConceptScore W2034333033C170493617 @default.
• W2034333033 hasConceptScore W2034333033C203014093 @default.
• W2034333033 hasConceptScore W2034333033C2778690821 @default.
• W2034333033 hasConceptScore W2034333033C2780192828 @default.
• W2034333033 hasConceptScore W2034333033C2780278673 @default.
• W2034333033 hasConceptScore W2034333033C2780394083 @default.
• W2034333033 hasConceptScore W2034333033C502942594 @default.
• W2034333033 hasConceptScore W2034333033C68324877 @default.

• next